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Cyanobacteria are phytoplanktonic microorganisms that are susceptible to the deleterious effects of 
pharmaceutical residues in the aquatic environment, which poses a challenge to the environment exposed 
to diverse pharmaceutical products and their potential effects. The objective of this study was to evaluate 
the effects of the antibiotic substances ciprofloxacin and chlorhexidine in pharmaceutical preparations 
on the growth and production of chlorophyll of two cyanobacterial strains, Microcystis aeruginosa and 
Microcystis panniformis, isolated from a lake in a Brazilian environmental protection area. The EC50 
and EC10 of chlorhexidine for M. aeruginosa were 206.4 μg/L and 108.5 μg/L, respectively, and for M. 
panniformis were 171.4 μg/L and 116.6 μg/L, respectively. The EC50 and EC10 of ciprofloxacin for M. 
aeruginosa were 17.24 μg/L and 3.21 μg/L, respectively, and for M. panniformis were 13.56 μg/L and 1.50 
μg/L, respectively. The toxicity of the antibiotic ciprofloxacin (drug) and chlorhexidine (standard solution) 
to the Microcystis species was demonstrated, and these species were both very sensitive to ciprofloxacin. 
Our results suggest that the strains of M. aeruginosa and M. panniformis may be affected by exposure 
to residues of ciprofloxacin (>1.5 μg/L), which may represent a risk to the survival of aquatic species.
Keywords: Ecotoxicological test. Antibiotics. Antiseptic. Contaminants of emerging interest. Growth 
inhibition.
INTRODUCTION
Recent  decades  have been marked by the 
intensification of pharmaceutical production and the 
introduction of new drugs (Kummerer, 2010; Baran et al., 
2011). This has led directly to the release of a large amount 
of pharmaceutical residues and their metabolites into the 
environment (Le-Minh et al., 2010; Kummerer, 2010). 
Studies in different locations have shown the presence of 
these residues in water bodies (Watkinson et al., 2009), in 
hospital effluents (Segura et al., 2009; Vasconcelos et al., 
2009; Rodrigues-Silva et al., 2014), in treatment waste 
water and sewage plants (Hirsch et al., 1999; Stumpf et al., 
1999; Homem, Santos, 2011; Dorival-García et al., 2013; 
Zhang, 2014) and even in treated effluents (Östman et al., 
2017) and drinking water (Yiruhan et al., 2010), 
demonstrating that conventional treatment processes are 
not fully effective in the removal of these residues.
Drug residues from the use of pharmaceuticals by 
the community, from the disposal of unused products, 
and from industrial and hospital effluents reach aquatic 
environments in their free forms or as metabolites and 
may affect the survival of aquatic species (Fatta-Kassinos, 
Meric, Nikolaou, 2011). Among pharmaceuticals, 
antimicrobials have been of interest due to their effects 
on the biota of impacted environments since there is no 
selectivity for the antimicrobial effect, and these drugs can 
act on aquatic microorganisms in the same way as they act 
on human pathogens (Kummerer, 2009; Kummerer, 2010; 
Wang, Chu, 2016).
Cyanobacteria, a group of unicellular, photosynthetic, 
and cosmopolitan microorganisms, are among the aquatic 
organisms that are potentially exposed to antimicrobial 
actions. Cyanobacteria are found in lakes, rivers, oceans, 
rocks, and soils; the aquatic environment is one of the most 
important habitats for these species (Paerl, Paul, 2012; 
Catherine et al., 2013). Because they are primary producers, 
toxic effects on cyanobacteria can be observed at other 
trophic levels (Kummerer, 2009; Grinten et al., 2010).
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The potential effects of antimicrobial residues 
on cyanobacteria stem from the morphological and 
biochemical similarity of these organisms to other 
bacteria, especially gram-negative bacteria; thus, there 
is a risk that antimicrobials may interfere with the 
equilibrium of the aquatic ecosystem (Kummerer, 2009; 
Grinten et al., 2010; Fatta-Kassinos, Meric, Nicolaou, 
2011). Resistance to antimicrobials can vary profoundly 
between cyanobacterial species and even between 
strains of the same species, which may compromise 
the equilibrium of aquatic communities (Lin et al., 
2011). The constitutive or acquired resistance of these 
organisms is also of concern due to the possibility of 
exchange of resistance genes between other bacteria and 
cyanobacteria (Lin et al., 2011). It is important to highlight 
that cyanobacteria have the same components related to 
gene transmission as other bacteria, such as plasmids and 
transposable elements, that facilitate genetic exchange 
(Dias et al., 2015).
Among cyanobacteria, the genus Microcystis is 
considered to have the greatest dominance in the global 
environment (Soares et al., 2013), participating in the 
regulation of the balance of the aquatic ecosystem. 
However, some species of this genus may be potent toxin 
producers (Corbel, Mougin, Bouaicha, 2014). Toxic 
agents released into the aquatic environment can lead 
to cell lysis of toxigenic strains of Microcystis with the 
release of toxins and can cause serious sanitation problems 
(Fan et al., 2014).
Ciprofloxacin is one of the most commonly detected 
antibiotics in effluents in several parts of the world due 
to its stability in the aquatic environment and its intense 
hospital and community usage (Segura et al., 2009; 
Rodrigues-Silva et al., 2014). These characteristics led 
to ciprofloxacin being included in the list of the ten drugs 
with high priority in the water treatment cycle (Zhou, 
Jiang, 2015).
In a study in Brazil, Martins et al. (2008) analysed 
the presence of drugs in effluents from a university hospital 
and found ciprofloxacin concentrations of up to 155.0 
μg/L. Ciprofloxacin concentrations have been reported in 
hospital effluents (Hartmann et al., 1998; Brown, 2004; 
Diwan, Lundborg, Tamhankar, 2013), as well as in aquatic 
environments in general (Kummerer, Henninger, 2003; 
Kummerer, 2009; Magdaleno et al., 2014; Östman et al., 
2017) (Table I). Recently, Östman et al. (2017) detected 
residues of ciprofloxacin at all stages of sewage and 
wastewater treatment plants, including treated effluents 
(Table I).
Chlorhexidine is a substance with antimicrobial 
activity that has been used for more than 50 years, with 
multiple applications due to its excellent antiseptic 
and broad spectrum activities, as well as its low cost 
(Chantal et al., 2009; Das, Ghosh, Bhattacharjee, 2015). 
Chlorhexidine is probably the most widely used biocide in 
antiseptic products, in handwashing and in oral products as 
well as a disinfectant in hospitals and in veterinary uses such 
as skin cleaners, teat dips and antiseptics. Chlorhexidine 
is also used for cold sterilization of surgical instruments 
and for disinfecting equipment (Kahrs, 1995; McDonnell, 
Russell, 1999; Bottoni, Caroli, Caracciolol, 2010; Das, 
Ghosh, Bhattacharjee, 2015; Environment and Climate 
Change Canada, 2017). This drug acts non-specifically 
on the microflora of different environments, generally in 
TABLE I - Detection of the antimicrobials ciprofloxacin and chlorhexidine in the aquatic environment
Drug Type of sample Local Study Drug Concentration detected (μg/L) Reference
Ciprofloxacin
University hospital 
wastewater Switzerland 3.0 to 87.0 Hartmann et al., 1998
Hospital wastewater United States 0.85 to 2.0 Brown, 2004
University hospital 
wastewater Brazil 19.0 to 155.0 Martins et al., 2008






0.009 to 0.106 Kummerer, 2009
Hospital wastewater India 3.07 Diwan, Lundborg, Tamhankar, 2013
Treated effluents Sweden 0.038 Östman et al., 2017
Chlorhexidine Treated effluents Sweden 0.028 Östman et al., 2017
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doses higher than antimicrobials of systemic use (Rizzotti, 
Rossi, Torriani, 2016).
According the Canadian document Draft Screening 
Assessment – Chlorhexidine and its Salts updated in 
2017, chlorhexidine tends to persist in water, sediment 
and soil. Although chlorhexidine has a low potential to 
bioaccumulate in aquatic organisms, data from acute and 
chronic toxicity for chlorhexidine indicate that it has the 
potential to cause adverse effects on aquatic organisms at 
low concentrations.
Chlorhexidine has been detected in a medical waste 
water treatment plant (Matsushima, Sakurai, 1984) and in 
treated effluents (Östman et al., 2017). Magdaleno et al. 
(2014) predicted that chlorhexidine would reach a 
concentration of 382.0 μg/L in effluents from a hospital in 
the city of Buenos Aires, Argentina (Table I).
The extensive use of these two antimicrobial 
substances raises the need to assess their effects on aquatic 
species. It should be noted that in addition to the drug 
itself, drug formulations involve the use of excipients that 
seek to improve therapeutic properties, but they may also 
affect the toxicity of aquatic species (Silva et al., 2014), 
indicating the need for research on the toxic effects of 
pharmaceutical products.
Microcystis is the genus of cyanobacteria with the 
broadest distribution in Brazil (Bicudo, Menezes, 2006). 
Microcystis aeruginosa and Microcystis panniformis, 
species isolated from Rio Doce State Park in previous 
studies, are toxin producers. The effects of pollutants, 
particularly antibiotics, on toxigenic species are of concern 
due the risk of release of toxins in the water.
In this study, the effects of ciprofloxacin and 
chlorhexidine, as pharmaceutical products, on the growth 
and chlorophyll production of Microcystis aeruginosa and 




The drug used was a generic injectable ciprofloxacin 
(0.2% in H2O), manufactured by the pharmaceutical 
company Isofarma Indústria Farmacêutica Ltda. – 
Brazil, containing NaCl, lactic acid, and hydrochloric 
acid (Cl ̄ 154 meq/L, Na+ 154 meq/L). The standard 
solution of chlorhexidine digluconate (20% in H2O) was 
obtained from Sigma-Aldrich – Germany. The nominal 
concentrations of the active pharmaceutical ingredients 
present in the products according to the manufacturer’s 
information were used. The reagents, solvents, and 
chemicals used in this study were of analytical or 
chromatographic grade. All the solutions were prepared 
using Milli-Q water (Millipore ®, USA).
Culture
The cyanobacteria Microcystis aeruginosa and 
Microcystis panniformis were isolated from water samples 
collected in a lake located in Rio Doce State Park, Minas 
Gerais, Brazil. The species were maintained in culture in 
the cyanobacteria bank of the Laboratory of Limnology 
Ecotoxicology and Aquatic Ecology at the Biological 
Science Institute of the Federal University of Minas Gerais 
(LIMNEA-ICB-UFMG).
Culture medium
The medium used to culture M. aeruginosa and 
M. panniformis was ASM-1 (Gorham et al., 1964). The 
pH was adjusted to 7.0 with either 0.1 mol/L HCl or NaOH 
solution.
Cell counting
The cells were counted in a Fuchs-Rosenthal 
counting chamber (New Optik®) with trypan blue staining 
(1 mL of culture to 500 μL trypan blue solution 2%). After 
sedimentation of the cells (10 minutes), they were counted 
under an optical microscope (Olympus CBA). From the 
counts, growth curves were built.
Optical Density (OD) 
After homogenization of the culture, 5 mL aliquots 
were removed and transferred into 10 mm cuvettes. The 
absorbance of the sample was determined at a wavelength 
of 700 nm.
Chlorophyll dosage
After homogenization of the culture, vacuum-
filtered 10 mL aliquots were removed. The membrane 
(Whatman GF/C 0.45 μm) was added to acetone (5 mL) 
as the extracting agent and macerated. The mixture was 
centrifuged for 20 minutes at 320.000 g (Sigma® 4K15). 
The supernatant was transferred to a 10 mm quartz 
cuvette, and spectrophotometric readings were taken at 
four different wavelengths: 630 nm, 647 nm, 664 nm and 
750 nm. The chlorophyll a concentration was calculated 
using the Jeffrey and Humphrey method (Jeffrey, 
Humphrey, 1975) and is expressed in mg/L.
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Growth inhibition tests 
Growth inhibition tests were performed following 
the OECD 201 Guidelines (2006), with some adaptations. 
Preliminary assays were conducted to establish the range 
of concentrations of ciprofloxacin and chlorhexidine 
separately to be used in the design of the experiments. A 
culture of cyanobacteria cells in the logarithmic phase of 
growth and containing approximately 106 cells/mL was 
inoculated in 250 mL erlenmeyer flasks containing 100 mL 
of ASM-1 medium. M. aeruginosa and M. panniformis 
were incubated, separately, at 25 ± 2 °C, under an 
irradiance of 98 mmoles.m-2.s1 and a 12-hour photoperiod 
until a cellular density of 106 cells/mL was obtained. 
The cultures were distributed into erlenmeyer flasks in 
triplicate, with increasing concentrations of ciprofloxacin 
and chlorhexidine. Pre-cultured cyanobacteria, test 
solutions and controls were grown on a shaking table 
under the same conditions for 96 hours. Cell growth was 
measured daily by optical density (OD) measurement at 
700 nm and chlorophyll dosage. All the experiments were 
carried out in triplicate.
Determination of the EC50 and EC10 of 
chlorhexidine and ciprofloxacin for M. aeruginosa 
and M. panniformis 
For the growth inhibition tests on the cyanobacteria, 
the effective concentrations of drugs required for a 50% 
(EC50) or 10% reduction in growth (EC10) were calculated 
using a regression analysis of the relationship between the 
inhibition of growth rate (r) and the concentration of the 
chlorhexidine or concentration of the ciprofloxacin on a 
natural logarithm (ln) scale. The inhibition growth rate 
coefficient (r) for each culture (tests and controls) was 
calculated at 96 hours according to Equation 1:
 r = ln X1 – ln X0 / t1 – t0 (1)
where X0 and X1 are the number of cells (optical density) 
at 0 and 96 hours, respectively; t0 denotes 0 days; t1 
denotes the fourth day; and r is the average specific growth 
rate for the period (day -1) (OECD, 2006). A significant 
concentration was defined as a concentration exhibiting a 
statistically significant reduction in fecundity (at p <0.05, 
one way analysis of variance - ANOVA).
RESULTS AND DISCUSSION
To determine the sensitivity of the M. aeruginosa and 
M. panniformis species to ciprofloxacin and chlorhexidine, 
the concentration ranges of these substances were 
established from preliminary tests to construct the growth 
inhibition curve. The concentration ranges of ciprofloxacin 
used were 2.1 μg/L to 29.4 μg/L and from 1.6 μg/L 
to 39.0 μg/L for M. aeruginosa and M. panniformis, 
respectively. For chlorhexidine, the concentration range 
for inhibition of the growth of the species was considerably 
higher, from 111.37 μg/L to 235.8 µg/L, and the same was 
used for both species.
Figure 1 shows the variations of the cell growth of 
the species exposed to the drugs for 96 hours.
For ciprofloxacin, a potent antimicrobial effect with 
irreversible growth inhibition at concentrations above 
6.0 μg/L was observed after 48 h of exposure (Figures 1a 
and 1c). The profile of the cyanobacterial growth inhibition 
curve of ciprofloxacin resembled that of Pasteurella 
multocida exposed to fluoroquinolones, as presented by 
Gehring and Riviere (2013), and those of several bacterial 
species reported by McKellar, Bruni and Jones (2004). 
This similarity was comparable to the similarity between 
the groups of bacteria and cyanobacteria.
It can be observed that the inhibitory effect of the 
growth of the species by ciprofloxacin was accentuated 
after 48 h of exposure. It is possible that this interval for 
the observation of effective inhibition of culture growth 
was due to the mechanism of action of ciprofloxacin. This 
antimicrobial acts intracellularly, inhibiting the enzyme 
DNA gyrase, making cell replication impossible; thus, the 
drug will have to penetrate the cell, meaning it takes time 
for it to reach the minimum inhibitory concentration for the 
effective inhibition of growth (Aldred, Kerns, Osheroff, 
2014; Rodrigues-Silva et al., 2014).
At the highest tested concentrations of chlorhexidine 
(197.0 μg/L and 236.0 µg/L) (Figures 1b and 1d), 
inhibition of cyanobacteria growth occurred in the first 
48 hours, with a reduction of the initial cell population. 
From the third day on, the culture containing chlorhexidine 
resumed growth.
Chlorhexidine can act on a cell rapidly; depending 
on the concentration and the pH, the maximum effect can 
occur within 20 seconds (McDonnell, Russell, 1999). 
After damage to the outer cell layers, the chlorhexidine 
molecules cross the cell membrane and attack the 
bacterial cytoplasm, followed by leakage of intracellular 
constituents. This mechanism of rapid action explains the 
early reduction of culture growth.
The recovery of the culture after the third day may 
have been due to cell adaptation mechanisms inherent to 
the species, or they may be acquired (McKella, Bruni, 
Jones, 2004). Another reason culture growth resumed 
might have been that all the drug had reacted or was 
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degraded. Chlorhexidine may undergo hydrolysis in 
alkaline solutions, yielding mainly p-chloroaniline (pCA) 
or reacting with different components of the medium 
(Mohammed, Abdel Aziz, 2017). pCA is the main product 
of its degradation pathway in alkaline conditions (Zong, 
Kirsch, 2012). According to Lin et al. (2015), light can also 
accelerate the by-product formation. pCA is very toxic if 
absorbed and may act as a human carcinogen (Mohammed, 
Abdel Aziz, 2017). According to Environment and Climate 
Change Canada (2017), chlorhexidine degradation in the 
natural environment is not significant, but in this study, 
the pH, light, and composition of the culture medium 
may have accelerated the degradation process, leading 
to the formation of products such as para-chloroaniline. 
However, by-product formation was not investigated in 
this study. We considered that the toxicity was due to the 
total products - chlorhexidine and its by-products. 
Growth inhibit ion curves as a  function of 
concentration are shown in Figure 2. From the equations 
of the curves, the EC50 and EC10 were obtained for each 
species.
The growth inhibition curves as a function of 
ciprofloxacin concentration did not present a linear 
behaviour. According to Rodrigues-Silva et al. (2014), 
ciprofloxacin may show a bactericidal or bacteriostatic 
effect on microbial populations. According to Gehring and 
Riviere (2013), there is a complex relationship between the 
dose of an antimicrobial drug and its effect on microbial 
growth, which occurs by bacteriostatic or bactericidal 
actions, depending on the concentration. In these cases, 
the relationship between dose and growth-inhibitory 
effect may not be described by a linear relationship 
between these variables and may require more complex 
mathematical models to represent the dose-response curve 
(Czok, Keller, 2007).
Using the logarithm of the ratio of ciprofloxacin 
concentration to the growth-inhibitory effect (Figures 2a 
and 2c), the concentrations that inhibited 50% of cell 
growth were calculated: 17.2 μg/L for M. aeruginosa and 
13.5 μg/L for M. panniformis (Table I).
The EC10 of both antimicrobials was determined for 
the two species. The EC10 values of ciprofloxacin were 3.2 
μg/L and 1.5 μg/L for M. aeruginosa and M. panniformis, 
respectively (Table II). The EC10, according to the limitations 
of the biological test, might not differ significantly from 
the no-observed-effect concentration (NOEC) (FAO, 
WHO, 2008) and may indicate the concentration limit 
where the harmful effects to the organisms tested begin to 
be observed. However, in this study, the value of NOEC 
could not be estimated due to the set of concentrations 
used and the statistical limitations of the model. However, 
it is important to note that the calculated EC10 values were 
lower than the concentrations that have been detected in 
different environments (Hartmann et al., 1998; Kummerer, 
Henninger, 2003; Brown, 2004; Martins et al., 2008; Diwan, 
Lundborg, Tamhankar, 2013).
The EC50 values of chlorhexidine for M. aeruginosa 
and M. panniformis were 206.4 μg/L and 171.4 μg/L, 
FIGURE 1 - Cellular density of M. aeruginosa exposed to (a) ciprofloxacin or (b) chlorhexidine. Cellular density of M. panniformis 
exposed to (c) ciprofloxacin or (d) chlorhexidine.
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respectively. The EC10 values of chlorhexidine were 
calculated, following a linear model between the inhibition 
percentage and the concentration of the test substance 
since the curve had a linear correlation higher than 
0.92. Concentrations leading to 10% inhibition of the 
growth of the species were 108.5 μg/L and 116.6 μg/L for 
M. aeruginosa and M. panniformis, respectively (Table II).
Previous studies have reported the EC50 of pure 
ciprofloxacin on the cyanobacterium M. aeruginosa. 
Robinson, Belden and Lydy (2005) reported an EC50 of 
17.0 μg/L, and Halling-Sorensen et al. (2000) obtained 
an EC50 equal to 5.0 μg/L. The inhibitory concentrations 
on M. aeruginosa found in our study are similar to 
those found by Robinson, Belden and Lydy (2005). The 
components of the injectable formulation other than 
ciprofloxacin apparently did add to the toxic effects 
evaluated in this study because the EC50 values were 
comparable to those reported in the literature for the non-
formulated antimicrobial.
Comparing the results of the study by Robinson et al. 
(2005) with that of Halling-Sorensen et al. (2000) and 
our study, differences in sensitivity between strains 
of the same species are observed. Dias et al. (2015), 
studying the antibiotic susceptibility of nine isolates of 
Microcystis aeruginosa, reported that the strains might 
acquire antibiotic resistance due to environmentally 
selective pressure by previous antibiotic exposure or by the 
transference of antibiotic resistance genes from bacteria. 
Yang et al. (2013), in assays of repeated exposure to 
tetracycline of the freshwater cyanobacterium Microcystis 
aeruginosa, observed that the species acquired resistance 
to antibiotics after the first exposure.
FIGURE 2 - Inhibition of growth of cultures of M. aeruginosa after 96 hours of exposure to ciprofloxacin (a) or chlorhexidine (b). 
Inhibition of growth of cultures of M. panniformis after 96 hours of exposure to ciprofloxacin (c) or chlorhexidine (d).
TABLE II - Effective concentrations of ciprofloxacin and chlorhexidine (µg/L) leading to 10% (EC10) and 50% inhibition (EC50) of 
Microcystis aeruginosa and Microcystis panniformis growth
Antimicrobial Substances Species EC10 µg/L (95% CI) EC50 µg/L (95% CI)
Ciprofloxacin
M. aeruginosa 3.21 [-0.66 - 7.09] 17.24 [1.76 - 32.72]
M. panniformis 1.50 [0.16 - 2.83] 13.56 [6.92 - 20.21]
Chlorhexidine
M. aeruginosa 108.47 [105.45 – 111.50] 206.38 [200.01 – 212.63]
M. panniformis 116.62 [112.79 – 120.45] 171.42 [169.34 – 173.49]
EC10: effective concentration leading to 10% inhibition of species growth. EC50: effective concentration leading to 50% inhibition 
of species growth. CI: confidence interval.
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It is possible that the origin of these species in 
different environments was related to their different levels 
of resistance to the same antimicrobial, depending on the 
mechanisms of acquired resistance, a widely demonstrated 
phenomenon in bacterial strains (Meagher et al., 2004; 
Aldred, Kerns, Osheroff, 2014).
Lawrence et al. (2008) observed the resistance of 
M. aeruginosa to chlorhexidine at concentrations of up 
to 100 μg/L, without significant inhibitory effects, but the 
researchers did not report the EC50. In our study, the EC50 
values of chlorhexidine for both species were also higher 
than 100 μg/L. Jesus et al. (2013) described an EC50 of 
62.2 μg/L for the algae Pseudokirchneriella subcapitata. 
This green algae, a common bioindicator, showed high 
susceptibility to chlorhexidine. The authors considered 
chlorhexidine very toxic to this species. 
One  of  the  most  common mechanisms of 
phytoplankton toxicity is the inhibition of photosynthesis. 
Chlorophyll  product ion by M. aeruginosa  and 
M. panniformis  was evaluated when exposed to 
chlorhexidine or ciprofloxacin at the same concentrations 
as in growth inhibition tests. The results are presented in 
Figure 3.
When estimating the production of chlorophyll 
per cell, it was observed that ciprofloxacin promoted a 
statistically significant inhibitory effect in both species 
compared to their respective controls (Figure 3a and 
3c), confirming the results observed by other researchers 
for different species of cyanobacteria exposed to 
various antimicrobials (Richards et al., 2004; Pan et al., 
2009; Aristilde, Melis, Sposito, 2010; Liu et al., 2012; 
Qian et al., 2012). According to Aristilde, Melis, and 
Sposito (2010), molecular structures of antimicrobials of 
the fluoroquinolone class, containing a quinolone ring and 
a secondary amino group, may inhibit the key enzymes 
in electron transport in photosystem II. Ciprofloxacin, 
specifically, interferes with the transfer of energy from the 
excitation of the molecules at that PS-II reaction centre 
(Deng, Pan, Zhang, 2015).
When exposed to chlorhexidine, M. aeruginosa 
showed no significant differences in the production of 
chlorophyll a per cell (Figure 3.b). For M. panniformis, 
production was inhibited only at concentrations above 
164.0 µg/L (Figure 3.d). These results indicate that 
chlorophyll biosynthesis appears to be one of the toxicity 
mechanisms of ciprofloxacin towards the Microcystis 
species evaluated and can be used for the calculation of 
EC50, as provided by the OECD protocol, but apparently 
is not suitable for the calculation for the inhibitory 
concentration of chlorhexidine.
There are some studies about growth inhibition of 
algae and cyanobacteria by antimicrobial agents, but it 
is not simple to compare them due different conditions 
of the tests and sources of the species. Yang et al. (2008) 
described the growth inhibition of the freshwater green 
alga Pseudokirchneriella subcapitata (Korschikov) 
FIGURE 3 - Chlorophyll a/cell after 96 hours of exposure of M. aeruginosa to ciprofloxacin (a) or chlorhexidine (b); and of M. 
panniformis to ciprofloxacin (c) or chlorhexidine (d). (*) indicates a significant difference between the control and the tests (P <0.05).
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Hindák by 12 antibacterial agents, including ciprofloxacin, 
whose IC50 was 6,700 μg/L. Hagenbuch and Pinckney 
(2012) evaluated the toxicity of ciprofloxacin towards 
two marine diatoms, Cylindrotheca closterium and 
Navicula ramosissima. The authors reported an EC50 
equal to 55,430 μg/L for C. closterium and 72,120 μg/L 
for N. ramosissima. These values were generally higher 
than the EC50 for freshwater species.
The growth and chlorophyll a production of 
Microcystis flos-aquae exposed to fluoroquinolone 
levofloxacin were investigated by Wan, Guo and Zhang 
(2014). The results indicated that when the levofloxacin 
concentration exceeded 10.0 μg/L, the growth of 
M. flos-aquae was significantly inhibited. Lützhoft, 
Halling-Sorensen and Jorgensen (1999) determined the 
EC50 values of several antimicrobials for M. aeruginosa, 
obtaining inhibitory concentrations ranging from 15.0 µg/L 
for sarafloxacin hydrochloride, a fluoroquinolone, to 
112.0 µg/L for trimethoprim. Other antimicrobials 
evaluated in the same study included flumequine 
(EC50 = 159.0 µg/L), oxolinic acid (EC50 = 180.0 µg/L), 
oxytetracycline hydrochloride (EC50 = 207.0 µg/L), and 
sulfadiazine (EC50= 135.0 µg/L). 
Cyanobacteria are prokaryotes with a cell wall and a 
similar structure to gram-negative bacteria. Cyanobacteria 
share many metabolic processes with other bacteria and 
can possess a similar sensitivity to antibiotics. In this 
study, the species M. aeruginosa and M. panniformis were 
very sensitive to ciprofloxacin, and the EC50 of this drug 
was lower in some cases than the minimum inhibitory 
concentrations (MICs) for pathogenic species such as 
Haemophilus spp. (MIC 2,000 to 6,000 µg/L) (Andrews, 
2001) and Salmonella typhimurium (MIC 25.0 μg/L) 
(Diwan, Lundborg, Tamhankar, 2013).
In Brazil, ciprofloxacin has been detected in 
hospital effluent at a concentration of up to 155.0 μg/L 
(Martins et al., 2008), and in other countries it has been 
detected in surface waters at concentrations ranging 
from 0.005 µg/L to 0.74 µg/L (Rodrigues-Silva et al., 
2014). Despite the dilution of the effluent in the natural 
aquatic environment, ciprofloxacin is a recalcitrant 
and poorly water-soluble contaminant that can be 
deposited in sediments (Frade et al., 2014). Furthermore, 
according to Lützhoft, Halling-Sorensen and Jorgensen 
(1999), the inhibitory concentrations of antimicrobials 
to certain aquatic species in laboratory settings may be 
underestimated for monoprotic and polyprotic compounds, 
such as ciprofloxacin, due to partitioning in the case of 
ionizable drugs. All of these aspects raise concerns about 
the environmental effects of antimicrobials
Chlorhexidine is also a persistent substance that can 
adsorb onto sediments. Although it presented a higher EC50 
for the studied species of Microcystis, its wide use and the 
dearth of studies on its concentration in the environment 
generate concern about its environmental impact.
O u r  r e s u l t s  s u g g e s t  t h a t  M .  a e r u g i n o s a 
and M. panniformis, common cyanobacteria in our 
environment, may be affected by exposure to ciprofloxacin, 
which may represent a risk to aquatic biodiversity.
CONCLUSION
The EC10 and EC50 of ciprofloxacin (pharmaceutical 
product) and chlorhexidine (standard solution) were 
determined for M. aeruginosa and M. panniformis. These 
species were very sensitive to ciprofloxacin, in terms 
of the EC50, compared to the inhibitory concentrations 
of other antimicrobials for cyanobacteria. Both species 
showed greater resistance to chlorhexidine. No data on 
chlorhexidine or ciprofloxacin concentrations are available 
in surface waters in Brazil. However, the presence of 
ciprofloxacin in hospital effluent has been reported, 
indicating its possible entry into the recipient water bodies. 
The EC10 of the test substances for the species evaluated, 
especially that of ciprofloxacin, are very low and alarming 
for environmental concerns. These results point to the need 
for studies to detect the presence of some drugs, including 
ciprofloxacin, in surface waters in Brazil, especially in 
water bodies that receive domestic or hospital effluent 
without adequate treatment.
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